Published in Dtsch Med Wochenschr on March 24, 2005
Outcome and quality of life one year after percutaneous coronary interventions in octogenarians. Neth Heart J (2008) 0.91
Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med (1997) 6.17
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation (2001) 5.87
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89
Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet (2000) 3.31
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J (2000) 3.07
Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res (2000) 2.52
Fiber optic lever displacement transducer. Appl Opt (1979) 2.49
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation (1999) 2.05
Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) Circulation (1995) 2.01
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation (2001) 1.83
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia (2000) 1.74
Cardiac angiosarcoma: case report and review of the literature. Z Kardiol (2005) 1.65
Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol (1984) 1.62
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res (2000) 1.60
A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). Eur Heart J (2000) 1.57
Coronary angioplasty in octogenarians. Quality of life and costs. Eur Heart J (1999) 1.50
Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation (1992) 1.50
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J (2002) 1.50
Holt-Oram syndrome. Circulation (1999) 1.49
Chiari's network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol (1995) 1.43
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris. Am J Cardiol (2001) 1.42
Membrane-covered stents: a new treatment strategy for saphenous vein graft lesions. Catheter Cardiovasc Interv (2001) 1.42
Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status. Eur Heart J (2000) 1.42
Long-term antiarrhythmic therapy with flecainide. Am J Cardiol (1984) 1.39
Protection of side-branches in coronary lesions with a new stent design. Cathet Cardiovasc Diagn (1998) 1.39
Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension. Circulation (1992) 1.39
Membrane-covered stents for the treatment of aortocoronary vein graft disease. Catheter Cardiovasc Interv (2000) 1.39
[The effect of a lower stimulation frequency on the AV synchronicity of VDD pacemakers]. Dtsch Med Wochenschr (1997) 1.38
[A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?]. Internist (Berl) (1999) 1.38
[Angina pectoris in normal coronary arteries (microvascular angina/syndrome X)]. Dtsch Med Wochenschr (1997) 1.38
Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol (2000) 1.36
Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol (1990) 1.29
"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol (2004) 1.28
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res (2000) 1.27
Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol (1999) 1.26
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int (1999) 1.25
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation (2001) 1.24
Catheter ablation of atrial flutter guided by electroanatomic mapping (CARTO): a randomized comparison to the conventional approach. J Cardiovasc Electrophysiol (2000) 1.23
New serum markers for acute myocardial infarction. N Engl J Med (1994) 1.23
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun (1999) 1.22
Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med (2001) 1.21
Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction. J Am Coll Cardiol (1984) 1.21
Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol (1981) 1.19
The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies. Clin Pharmacol Ther (1976) 1.17
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J (2003) 1.16
Flow-dependent coronary artery dilatation in humans. Circulation (1989) 1.16
In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res (2000) 1.12
The temporal and spatial distribution of macrophage subpopulations during arteriogenesis. Curr Vasc Pharmacol (2013) 1.11
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation (1989) 1.09
Echocardiography in assessing acute pulmonary hypertension due to pulmonary embolism. Am J Cardiol (1980) 1.09
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
Beta-blocker withdrawal syndrome? Lancet (1979) 1.08
Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine. Clin Pharmacol Ther (1977) 1.07
Cardiac metastasis of a renal cell adenocarcinoma investigated by cardiac magnetic resonance imaging. Clin Res Cardiol (2006) 1.06
Enhanced elimination of warfarin during treatment with cholestyramine. Br J Clin Pharmacol (1978) 1.06
ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J (1990) 1.05
Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists. Lancet (2000) 1.05
Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol (1996) 1.05
Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. Biochem Biophys Res Commun (2000) 1.02
Several unsuccessful internal and external defibrillations during active can ICD implantation in a patient with pneumothorax. Pacing Clin Electrophysiol (1998) 1.01
Anticoagulant activity of the enantiomers of acenocoumarol. Br J Clin Pharmacol (1978) 1.00
Risk of transesophageal echocardiography in awake patients with cardiac diseases. Am J Cardiol (1988) 1.00
Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol (2001) 0.99
The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol (2007) 0.98
Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann N Y Acad Sci (1999) 0.98
Tachyarrhythmias following coronary artery bypass graft surgery: epidemiology, mechanisms, and current therapeutic strategies. Thorac Cardiovasc Surg (1997) 0.98
[Intermittent atrial fibrillation/flutter: contraindication for implantation of a dual chamber pacemaker?]. Z Kardiol (1996) 0.97
Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J (1988) 0.97
Coronary artery anomalies. Part I: Recent insights from molecular embryology. Z Kardiol (2004) 0.97
Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation (1999) 0.97
Coronary artery anomalies Part II: recent insights from clinical investigations. Z Kardiol (2005) 0.96
Stimulatory effects of DB-c-AMP and adrenaline on myocardial contraction and 45Ca exchange. Experiments at reduced calcium concentration and low frequencies of stimulation. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96
Prospective evaluation of the coronary sinus anatomy in patients undergoing electrophysiologic study. Clin Cardiol (1999) 0.96
Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost (2011) 0.95
Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators. J Am Coll Cardiol (1998) 0.95
Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man. Eur J Clin Pharmacol (1976) 0.95
Diagnosis of hidden pacemaker lead sepsis by transesophageal echocardiography and a new technique for lead extraction. Am Heart J (1989) 0.95
Embryotoxicity of broadband high-frequency noise in the CD-1 mouse. J Toxicol Environ Health (1982) 0.95
Pharmacokinetics of azapropazone following single oral and intravenous doses. Arzneimittelforschung (1979) 0.95
Treatment of phenprocoumon intoxication with cholestyramine. Br Med J (1977) 0.95
The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95
Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J (1991) 0.94
Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol (2000) 0.94
Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clin Chem (1998) 0.94
Echocardiographic findings in patients with proved pulmonary embolism. Am Heart J (1986) 0.93
Influence of cyclization and acyl substitution on the inotropic effects of adenine nucleotides. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.93
Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography. Br Heart J (1993) 0.93
Papillary fibroelastomas of the heart. Thorac Cardiovasc Surg (2008) 0.92
Metastatic malignant melanoma initially seen as congestive heart failure: diagnosis by transesophageal echocardiography. Am Heart J (1994) 0.91
Psychiatric conditions in patients with recurrent unexplained syncope. Europace (2001) 0.91